Literature DB >> 17301486

Leishmanial proteins can correct human mitochondrial mutations.

Anuradha Lohia1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17301486     DOI: 10.1007/bf02708400

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


× No keyword cloud information.
  6 in total

1.  Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells.

Authors:  Bidesh Mahata; Saikat Mukherjee; Sumita Mishra; Arun Bandyopadhyay; Samit Adhya
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

Review 2.  Mitochondrial diseases: gene mapping and gene therapy.

Authors:  E S Lander; H Lodish
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

4.  Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells.

Authors:  Olga A Kolesnikova; Nina S Entelis; Clarisse Jacquin-Becker; Francine Goltzene; Zofia M Chrzanowska-Lightowlers; Robert N Lightowlers; Robert P Martin; Ivan Tarassov
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

5.  Allosteric regulation of tRNA import: interactions between tRNA domains at the inner membrane of Leishmania mitochondria.

Authors:  Srikanta Goswami; Saibal Chatterjee; Suvendra Nath Bhattacharyya; Sudarshana Basu; Samit Adhya
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

6.  In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes.

Authors:  J P Masucci; M Davidson; Y Koga; E A Schon; M P King
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.